Related Experiment Video
Updated: Apr 23, 2026
07:12
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
6.5K
Diabetic dyslipidemia
Metabolism: Clinical and Experimental
|September 23, 2014
Summary
Diabetic dyslipidemia, marked by abnormal lipid levels, significantly increases cardiovascular risk in diabetics. Statin therapy offers the greatest benefit for managing these risks and improving patient outcomes.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Syndrome
Background:
- Diabetic dyslipidemia involves high triglycerides, low HDL-cholesterol, high LDL-cholesterol, and small dense LDL particles.
- These lipid abnormalities are a primary driver of increased cardiovascular risk in patients with diabetes.
- The pathophysiology involves insulin resistance, elevated free fatty acids, inflammation, and altered lipoprotein metabolism.
Purpose of the Study:
- To review the pathophysiology of diabetic dyslipidemia.
- To examine the link between diabetic dyslipidemia and cardiovascular disease.
- To discuss current and potential management strategies for diabetic dyslipidemia.
Main Methods:
- Literature review of studies on diabetic dyslipidemia pathophysiology and cardiovascular outcomes.
- Analysis of the role of lifestyle, glucose control, and pharmacologic interventions.
- Evaluation of evidence for various lipid-lowering therapies.
Main Results:
- Diabetic dyslipidemia is complex, stemming from multiple metabolic derangements.
- Statin therapy demonstrates significant efficacy in reducing cardiovascular risk in diabetic patients.
- The benefits of other lipid-lowering agents (ezetimibe, fibrates, etc.) are less established, with many showing negative outcome trial results.
Conclusions:
- Diabetic dyslipidemia is a critical factor in the elevated cardiovascular risk associated with diabetes.
- Most patients with diabetes should be considered for statin therapy due to its proven benefits.
- Further research is needed to clarify the role of alternative lipid-lowering drugs in managing diabetic dyslipidemia and its associated risks.
Related Concept Videos
01:27Diabetic Retinopathy
45
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
45
01:19Type I Diabetes III: Clinical Manifestations
14
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
14
01:22Diabetic Neuropathy
35
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
35
01:31Diabetic Foot Ulcer
23
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
23
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
837
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
837